Better Therapeutics is pioneering digital therapeutic approaches for treating cardiometabolic diseases. The incidences of diabetes, hypertension and heart disease are all increasing along with rising healthcare costs. Instead of developing therapies that target the consequences of these diseases, Better is creating digital therapies that target the cause. This includes modifiable behaviors such as poor diet, sedentary activity and smoking. Prescription digital therapeutics are regulated mobile applications that provide the delivery system for behavioral therapy. Better’s lead therapeutic candidate, BT-001, is a Nutritional Cognitive Behavioral Digital Therapy for patients with type 2 diabetes to target the behavioral and emotional patterns and coping skills underlying eating behaviors.

Better Therapeutics

Founded: 2015
Location: San Francisco, CA
Employee range: 51-100
Funding: 100-500M

Short description:

Drug notes:

Long description:

Jobs: